Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

ASH 2011: B-cell depletion, remissions of malignancy, and cytokine-associated toxicity in a clinical trial of T-cells genetically-engineered to express an anti-CD19 chimeric antigen receptor

ASH 2011: B-cell depletion, remissions of malignancy, and cytokine-associated toxicity in a clinical trial of T...

ASH 2011: Novel chromosomal rearrangements and sequence mutations in high-risk ph-like acute lymphoblastic leukaemia

ASH 2011: Novel chromosomal rearrangements and sequence mutations in high-risk ph-like acute lymphoblastic...

ASH 2011: Fractionated doses of gemtuzumab ozogamicin (GO) combined to standard chemotherapy (CT) improve event-free and overall survival

ASH 2011: Fractionated doses of gemtuzumab ozogamicin (GO) combined to standard chemotherapy (CT) improve event...

White adipose tissue used in lipotransfer can promote cancer progression

White adipose tissue used in lipotransfer can promote cancer progression

Scientists discover how to beat resistance to standard leukaemia drug

Scientists discover how to beat resistance to standard leukaemia drug

Tumour-targeting compound points way to new personalised treatments

Tumour-targeting compound points way to new personalised treatments

Trial finds new drug combo increases remission time for lymphoma patients

Trial finds new drug combo increases remission time for lymphoma patients

Tamoxifen for male breast cancer sees significant side effects

Tamoxifen for male breast cancer sees significant side effects

Mass General Hospital Cancer Center and Vall d'Hebron Institute of Oncology combine forces in biomarker alliance

Mass General Hospital Cancer Center and Vall d'Hebron Institute of Oncology combine forces in biomarker alliance

Combination therapy shows potent tumour growth inhibition in preclinical studies

Combination therapy shows potent tumour growth inhibition in preclinical studies

More from ecancer